|
LOC653653 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.357200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.379400E-01 |
| Normal-vs-Stage2 |
5.529800E-01 |
| Normal-vs-Stage3 |
1.984380E-01 |
| Normal-vs-Stage4 |
5.128600E-01 |
| Stage1-vs-Stage2 |
6.104200E-01 |
| Stage1-vs-Stage3 |
1.383180E-01 |
| Stage1-vs-Stage4 |
5.487800E-01 |
| Stage2-vs-Stage3 |
7.358400E-01 |
| Stage2-vs-Stage4 |
9.759800E-01 |
| Stage3-vs-Stage4 |
6.495400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.009000E-01 |
| Normal-vs-AfricanAmerican |
8.668400E-01 |
| Normal-vs-Asian |
9.175000E-01 |
| Caucasian-vs-AfricanAmerican |
6.372000E-01 |
| Caucasian-vs-Asian |
5.979800E-01 |
| AfricanAmerican-vs-Asian |
9.504000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.946400E-01 |
| Normal-vs-Female |
5.989200E-01 |
| Male-vs-Female |
6.268800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.689800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.543160E-01 |
| Normal-vs-Age(61-80Yrs) |
3.741400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.819600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.717700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.073830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.733200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.563600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.159200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.578200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.244200E-01 |
| Classical-VS-Follicular |
1.707540E-02 |
| Classical-VS-Other |
1.620430E-01 |
| Classical-VS-Normal |
9.804800E-01 |
| Tall-VS-Follicular |
1.833840E-01 |
| Tall-VS-Other |
1.635200E-01 |
| Tall-VS-Normal |
9.425200E-01 |
| Follicular-VS-Other |
5.511600E-01 |
| Follicular-VS-Normal |
8.507900E-02 |
| Other-VS-Normal |
1.081430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.561400E-01 |
| Normal-vs-N1 |
2.498800E-01 |
| N0-vs-N1 |
8.533600E-01 |
|
|
